- Home
- NVX vs CVRX Comparison
NVX vs CVRX Comparison
Compare NVX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- CVRX
- Stock Information
- Founded
- NVX 2012
- CVRX 2000
- Country
- NVX Australia
- CVRX United States
- Employees
- NVX N/A
- CVRX N/A
- Industry
- NVX Industrial Machinery/Components
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NVX Miscellaneous
- CVRX Health Care
- Exchange
- NVX Nasdaq
- CVRX Nasdaq
- Market Cap
- NVX 176.8M
- CVRX 174.4M
- IPO Year
- NVX N/A
- CVRX 2021
- Fundamental
- Price
- NVX $1.17
- CVRX $7.56
- Analyst Decision
- NVX
- CVRX Buy
- Analyst Count
- NVX 0
- CVRX 7
- Target Price
- NVX N/A
- CVRX $14.50
- AVG Volume (30 Days)
- NVX 389.6K
- CVRX 302.9K
- Earning Date
- NVX 01-01-0001
- CVRX 08-04-2025
- Dividend Yield
- NVX N/A
- CVRX N/A
- EPS Growth
- NVX N/A
- CVRX N/A
- EPS
- NVX N/A
- CVRX N/A
- Revenue
- NVX $5,854,424.00
- CVRX $52,870,000.00
- Revenue This Year
- NVX $135.22
- CVRX $11.53
- Revenue Next Year
- NVX $1,647.66
- CVRX $18.61
- P/E Ratio
- NVX N/A
- CVRX N/A
- Revenue Growth
- NVX N/A
- CVRX 25.62
- 52 Week Low
- NVX $0.81
- CVRX $4.30
- 52 Week High
- NVX $2.73
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- NVX 42.46
- CVRX 50.10
- Support Level
- NVX $1.51
- CVRX $8.10
- Resistance Level
- NVX $2.04
- CVRX $8.81
- Average True Range (ATR)
- NVX 0.19
- CVRX 0.58
- MACD
- NVX -0.04
- CVRX -0.06
- Stochastic Oscillator
- NVX 6.45
- CVRX 29.89
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.